Shoulder Innovations Launches Full Commercial Release of InSet™ I-135RFX Humeral Stem
Shoulder Innovations, Inc. (NYSE: SI) has launched the full commercial release of its InSet™ I-135RFX Humeral Stem, following a successful limited market release and FDA clearance for additional fracture indications. The product is now available for use in all primary, revision, and fracture total shoulder arthroplasty procedures.
Tickers: $SI
Topics: FDA clearance medical devices medical technology product launch shoulder surgery